Effect of Pneumatic Compression on Diaphragmatic Excursion in Hemodialysis Patients With Low Back Dysfunction
調査の概要
詳細な説明
The prevalence of the musculoskeletal manifestations is high (76.4%) in the hemodialysis population .Pain is the most frequently reported symptom (44.9%). Seven studies (28%) reported back pain With a prevalence ranging from 14.29%-52%. In hemodialysis patients, Low back pain (LBP) can be attributed to sedentary lifestyle ،low physical performance, muscular weakness ،psychological factors, altered metabolic activity of the bones and joints, and rare causes such as tumor, spinal infection, and osteoporotic fractures.
Diaphragm is an important component of spine lumbar stability. In presence of low back pain ،there may be some alterations in this muscle like other muscles that are responsible for lumbar stabilization. Respiratory muscle training (RMT) has been proven to reduce pain intensity and improve respiratory muscle strength, physical function, balance, and consequently، the overall quality of life in several population groups.
Pneumatic compression device had a significant improvement in pulmonary functions and inspiratory muscle training. And pneumatic compression can be considered as an effective component for pulmonary rehabilitation in chronic obstructive pulmonary lung disease. patients. Up to investigated knowledge, No previous studies conducted to explore the effect of pneumatic compression versus Inspiratory muscle training on diaphragmatic function in patients with low back dysfunction .
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Hagar Azab, Master
- 電話番号:01018746727
- メール:hagaratif92@gmail.com
研究連絡先のバックアップ
- 名前:Shimaa Ali, As professor
- 電話番号:01144242511
- メール:shymaaali@pt.cu.edu.eg
研究場所
-
-
-
Cairo、エジプト
- Hagar Atif Azab
-
-
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Patients have been on regular hemodialysis (three sessions a week) at least 6 months before the start of the study
- Patients 'Age between 40 and 60 years old
- Patients have not participated in any physical activity program at least 6 months before the start of the study
- Patients have chronic back pain > 3months
- Patients has non specific low back pain
- Body mass index (BMI) from 25 to 34.9 kg/m2.
- Patients are clinically and medically stable
Exclusion Criteria:
- Instability of patient's medical condition
- Patients with chest infection
- Inability to comprehend and follow instructions as in dementia or speech problems such as dysphasia,
- uncontrolled diabetes mellitus,
- Persistent systolic Blood Pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg
- Chronic lung disease which result in significant oxygen desaturation on exercise or pulmonary congestion
- Patients with lupus nephritis.
- Patients with Spondylodiscitis , Compression fracture, Spinal stenosis
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Pneumatic compression and inspiratory muscle Trainer group
Participants will receive resisted inspiratory exercises using pneumatic compression abdominal belt in addition to inspiratory muscle Trainer (3 sessions per week) for 12 weeks
|
Training program in the form of resisted inspiratory exercises using pneumatic compression device with abdominal sleeve on the top portion of the abdominal cavity beneath the xiphoid process.
The patient used a pursed-lip breathing method to exhale after inhaling slowly through the nose such that the stomach slid out against the abdominal sleeve of the device.
For 12 weeks, three times per week, the workout consisted of 10 sets with 4-5 breaths in each set and a rest period of 2-3 minutes.
the subject underwent training in the form of six sets of five deep breaths against the trainer, with 1-2 minutes of rest in between sessions.
Depending on their rate of perceived exertion, the patient determined the maximum training load at which they could effectively perform 10 breaths at maximum resistance.
A load equivalent to 30% of the patient's maximum inspiratory effort was used to begin the training .This unique load gradually increased as the inspiratory muscle got stronger.
At the conclusion of the three months, the training programmer had expanded by 5% to 10% per week, reaching 60% of the maximum inspiratory pressure.
|
|
アクティブコンパレータ:Inspiratory muscle Trainer group
Participants will receive only training of the inspiratory muscles by (Threshold Inspiratory Muscle Trainer) (3 sessions per week) for 12 weeks
|
the subject underwent training in the form of six sets of five deep breaths against the trainer, with 1-2 minutes of rest in between sessions.
Depending on their rate of perceived exertion, the patient determined the maximum training load at which they could effectively perform 10 breaths at maximum resistance.
A load equivalent to 30% of the patient's maximum inspiratory effort was used to begin the training .This unique load gradually increased as the inspiratory muscle got stronger.
At the conclusion of the three months, the training programmer had expanded by 5% to 10% per week, reaching 60% of the maximum inspiratory pressure.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Diaphragmatic excursion
時間枠:12 weeks
|
Ultrasonography is an ideal tool and easy to be operated for evaluating diaphragm function.
Low thickening ratio at forced respiration is an early indicator of diaphragm dysfunction and is associated with adverse clinical outcomes in hemodialysis (HD) patients.
These findings suggest that routine screening for diaphragm dysfunction is in HD patients and intervention of diaphragm dysfunction is expected to be a novel strategy for improving the clinical outcomes in HD patients.
|
12 weeks
|
|
Pain intensity
時間枠:12 weeks
|
Visual analogue scale (VAS) will be used to assess pain intensity.
it is 10 centimeter line with 2 ends; 0 indicates no pain and 10 indicates the worst pain.
|
12 weeks
|
|
functional capacity
時間枠:12 weeks
|
The 6 Minute Walk Test (6MWT) is a sub-maximal exercise test used to assess aerobic capacity and endurance.
The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
The patient will rest comfortably for 10 minutes prior to the test.
During this time blood pressure and heart rate are measured and potential contraindications assessed.
The 6MWT will be performed on the walking track in which is 30 meters on one lap and two small cones will be used to mark the walking track boundaries.
|
12 weeks
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Functional disability
時間枠:12 weeks
|
The Oswestry Disability Index (ODI) has become well-researched gold standard for assessing the severity of disability caused by back pain.
The ODI covers 1 item on pain and 9 items on activities of daily living (personal care, lifting, walking، sitting, standing, sleeping, sex life, social life, and traveling.
Each section contains 6 statements scored from 0 to 5, where 0 is no disability and 5 is the maximum.
Scores are calculated as a percentage: (Total Points ÷ Total Possible Points) × 100.
|
12 weeks
|
|
Health-related Quality of life
時間枠:12 weeks
|
The SF-12 Health Survey Questionnaire is used to evaluate the health-related quality of life (HR-QoL) before and after the interventions.
The SF-12 consists of 12 questions that examine eight different health domains in order to determine physical and mental health.
General Health (GH), Physical Functioning (PF), Role Physical RP), and Body Pain (BP) are the physical health domains.
Vitality) VT), Social Functioning (SF), Role Emotional (RE), and Mental Health (MH) are mental health-related scales.
A score above 50 indicates better-than-average health, while a score below 50 indicates below-average perceived health.
|
12 weeks
|
協力者と研究者
スポンサー
捜査官
- スタディディレクター:Hany Saeed, As Professor、Cairo University
- スタディチェア:Heba Abd Elghafar, As professor、Cairo University
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- P.T.REC/012/005447
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。